Streetbeat News

SXTP

60 Degrees Pharmaceuticals, Inc.

https://60degreespharma.com

Industry

Biotechnology

60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.

Open

0.95

Mkt cap

2.1M

Volume

32K

High

0.95

P/E Ratio

-0.09

52-wk high

18.36

Low

0.86

Div yield

N/A

52-wk low

0.70

Shares of several companies including Connexa Sports Technologies, Elutia, Galera Therapeutics, Senti Biosciences, Neptune Wellness Solutions, Aclarion, Cybin, Avinger, SelectQuote, and Bit Brother Limited are trading higher in pre-market. Elutia's shares rose after the sale of its Orthobiologics business unit to Berkeley Biologics. Galera scheduled a meeting with the FDA to discuss next steps for its radiotherapy avasopasem. Neptune Wellness announced intention to spinout Sprout Organics. Cybin shares surged after hedge fund owner Steve Cohen invested $19 million in the company. On the other hand, shares of Digital Transformation Opportunities Corp., Rocket Lab USA, Novo Integrated Sciences, 60 Degrees Pharmaceuticals, Terran Orbital Corporation, Perspective Therapeutics, MSP Recovery, T2 Biosystems, SCWorx Corp., and FLJ Group Limited are trading lower in pre-market.

Portfolio Pulse from Lisa Levin

September 19, 2023 | 11:59 am

60 Degrees Pharma has withdrawn its Covid Phase 2B Investigational New Drug, with plans to resubmit after assessing its ability to meet FDA requirements. This has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 10:30 am

60 Degrees Pharma has withdrawn its Phase IIB Investigational New Drug (IND) application for a COVID-19 treatment. The company plans to resubmit the application after assessing its ability to meet FDA requirements.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 8:17 pm

60 Degrees Pharmaceuticals has announced that the New Microbes and New Infections journal has published non-clinical study results showing that Tafenoquine exhibits broad-spectrum antifungal activity and decreases fungal burden in the lungs in an invasive pulmonary mouse.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2023 | 11:59 am

On Tuesday, 99 stocks hit new 52-week lows. The largest company by market cap to set a new low was Insulet (NASDAQ:PODD), while the smallest was SciSparc (NASDAQ:SPRC). BTC Digital (NASDAQ:METX) saw a significant downward movement, trading down 16.67% to reach a new low. Putnam Premier Income (NYSE:PPT) shares were the most resilient, rebounding from its new low with a 0.0% rise.

Portfolio Pulse from Benzinga Insights

August 29, 2023 | 6:37 pm

60 Degrees Pharmaceuticals has received an additional US patent for Tafenoquine, a drug used for the prevention of Plasmodium Falciparum Malaria. The patent will strengthen the company's intellectual property rights and potentially increase its market share.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 11:31 am

60 Degrees Pharmaceuticals has registered a Phase IIB study of Tafenoquine for the treatment of COVID-19 on ClinicalTrials.gov. The study is named ACLR8-LR.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:32 am

On Wednesday, 155 companies set new 52-week lows. The largest company by market cap to set a new 52-week low was Estee Lauder Cos (NYSE:EL). The smallest company by market cap to set a new 52-week low was SenesTech (NASDAQ:SNES). Siyata Mobile (NASDAQ:SYTA)'s stock fell the most, as it traded down 7658.62% to reach a new 52-week low. Sutro Biopharma (NASDAQ:STRO) was the biggest winner of the bunch, with shares actually trading up 0.0% after it rebounded from its new 52-week low.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 4:27 pm

On Monday, 149 companies reached new 52-week lows. The largest company by market cap to hit a new 52-week low was NextEra Energy (NYSE:NEE), while the smallest was Esports Entertainment (NASDAQ:GMBL). Bionano Genomics (NASDAQ:BNGO) saw the most pronounced move, with shares trading down 842.14% to hit its new 52-week low. Northwest Natural Hldg (NYSE:NWN) shares gained 0.0%, rebounding after it reached its 52-week low.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 4:13 pm

On Friday, 73 companies reached new 52-week lows. Pfizer was the largest firm by market cap to set a new 52-week low, while INVO Bioscience was the smallest. Fangdd Network Group's shares dropped the most, while Harbor Custom Dev's stock rebounded the most.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 6:06 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.